Calidi Biotherapeutics Net Income vs. Target Price
| CLDI Stock | 0.75 0.03 3.85% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -19.9 M | Current Value -20.9 M | Quarterly Volatility 7.5 M |
For Calidi Biotherapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Calidi Biotherapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Calidi Biotherapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Calidi Biotherapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Calidi Biotherapeutics over time as well as its relative position and ranking within its peers.
Check out Trending Equities. Is there potential for Biotechnology market expansion? Will Calidi introduce new products? Factors like these will boost the valuation of Calidi Biotherapeutics. Projected growth potential of Calidi fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Calidi Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Calidi Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Calidi's accounting equity. The concept of intrinsic value - what Calidi Biotherapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Calidi Biotherapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Calidi Biotherapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Calidi Biotherapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Calidi Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Calidi Biotherapeutics Target Price vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Calidi Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Calidi Biotherapeutics value to that of its competitors to determine the firm's financial worth. Calidi Biotherapeutics is rated below average in net income category among its peers. It is currently under evaluation in target price category among its peers . The last year's value of Net Loss was reported at (19.93 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Calidi Biotherapeutics' earnings, one of the primary drivers of an investment's value.Calidi Target Price vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Calidi Biotherapeutics |
| = | (22.21 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Calidi Biotherapeutics | = | 120.0 |
Calidi Target Price Comparison
Calidi Biotherapeutics is currently under evaluation in target price category among its peers.
Calidi Biotherapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Calidi Biotherapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Calidi Biotherapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Calidi Biotherapeutics' change in net profit over the period of time. It can combine multiple indicators of Calidi Biotherapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -25.2 K | -26.5 K | |
| Net Interest Income | -839.7 K | -881.7 K | |
| Operating Income | -19.6 M | -20.6 M | |
| Net Loss | -20 M | -21 M | |
| Income Before Tax | -20 M | -21 M | |
| Total Other Income Expense Net | -377.1 K | -358.2 K | |
| Net Loss | -22.9 M | -24 M | |
| Net Loss | -20 M | -21 M | |
| Income Tax Expense | 16.1 K | 12.3 K | |
| Change To Netincome | 9.5 M | 10 M | |
| Net Loss | (38.33) | (40.24) | |
| Income Quality | 0.80 | 0.58 | |
| Net Income Per E B T | 0.90 | 0.94 |
Calidi Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Calidi Biotherapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Calidi Biotherapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Calidi Biotherapeutics' important profitability drivers and their relationship over time.
Calidi Biotherapeutics Earnings per Share Projection vs Actual
Use Calidi Biotherapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Calidi Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calidi Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Calidi Biotherapeutics Pair Trading
Calidi Biotherapeutics Pair Trading Analysis
The ability to find closely correlated positions to Calidi Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Calidi Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Calidi Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Calidi Biotherapeutics to buy it.
The correlation of Calidi Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Calidi Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Calidi Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Calidi Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Calidi Biotherapeutics position
In addition to having Calidi Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Funds Thematic Idea Now
Precious Metals Funds
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
To fully project Calidi Biotherapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Calidi Biotherapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Calidi Biotherapeutics' income statement, its balance sheet, and the statement of cash flows.